Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Phase II trial of the novel combination, decitabine, venetoclax, and ponatinib achieved bone marrow remission in 80% of ...

The bioengineering company Ossium Health has created a new program that offers deep-frozen bone marrow from deceased organ ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Davis is able to focus on different numbers now. A linebacker, Davis ranks third on the team with 12 tackles. Last week, ...

Before receiving treatment for acute myeloid leukemia, I made it a point to take advantage of all the resources that were ...

Venetoclax is under clinical development by AbbVie and currently in Phase II for Secondary Acute Myeloid Leukemia.

A former Alabama news anchor who worked at stations in Huntsville and Birmingham has died after a battle with acute myeloid ...

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...